Merck MRK
NYSE MRK
$145.93 +0.74 (+0.51%)
As of: Oct 16, 2026 · 3:59 PM EDT

Merck (MRK) Consolidated Net Income (2009 - 2026)

Updated

Merck's Consolidated Net Income was -$1.34 billion in Q2 2026, compared with $4.43 billion a year earlier.

Analysis

Merck (MRK) Consolidated Net Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Merck's Consolidated Net Income was $3.17 billion through Jun 30, 2026, down 80.7% year-over-year; for FY2025, it was $18.26 billion, up 6.6% from FY2024.

  • Consolidated Net Income shows a five-year compound annual growth rate of 20.9% (FY2020 to FY2025).
  • In earlier years, Consolidated Net Income was $17.13 billion in FY2024, $377 million in FY2023 (-97.4%), $14.53 billion in FY2022 (+11.2%) and $13.07 billion in FY2021 (+84.5%).
  • Quarterly Consolidated Net Income has moved between -$5.97 billion (Q2 2023) and $5.79 billion (Q3 2025) over five years.
  • Compared with a year earlier, Consolidated Net Income was higher in two of the last five quarters, with growth averaging 3.3%.
  • The best year-over-year quarter for Consolidated Net Income over five years was Q2 2022 (growth of 155.4%); the worst was Q1 2023 (a decline of 34.4%).
  • Per Business Quant data, MRK's Consolidated Net Income in the three quarters before Q2 2026 was -$4.24 billion (Q1 2026), $2.96 billion (Q4 2025) and $5.79 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 5.53 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.62 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.51 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -10.50 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -237.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.34 Bn
Mar 31, 2026 -4.24 Bn
Dec 31, 2025 2.96 Bn
Sep 30, 2025 5.79 Bn
Jun 30, 2025 4.43 Bn
Mar 31, 2025 5.09 Bn
Dec 31, 2024 3.74 Bn
Sep 30, 2024 3.16 Bn
Jun 30, 2024 5.46 Bn
Mar 31, 2024 4.77 Bn
Dec 31, 2023 -1.23 Bn
Sep 30, 2023 4.75 Bn
Jun 30, 2023 -5.97 Bn
Mar 31, 2023 2.83 Bn
Dec 31, 2022 3.02 Bn
Sep 30, 2022 3.25 Bn
Jun 30, 2022 3.95 Bn
Mar 31, 2022 4.31 Bn
Dec 31, 2021 3.76 Bn
Sep 30, 2021 4.57 Bn
API Access

Merck Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=MRK&period=max&api_key=YOUR_API_KEY